Public Issue of Parabolic Drugs Avoid

Public Issue of Parabolic Drugs



EPS: 4.85



P/E Ratio 17.5



Expensive Issue as Dishaman Pharma available at pe multiple of 14 only so my advise to all viewers that not to subscribe this issue